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Background: Detailed epidemiology of Chronic Respiratory Diseases (CRDs) and of their risk and protective factors is
needed to plan preventive interventions to reduce the burden of CRDs on population health. This study determines
the prevalence of doctor-diagnosed CRDs and its associated factors in the adult Italian population. Methods: Data
was collected from adults participating in the ongoing cross-sectional Italian Behavioural Risk Factor Surveillance
System (PASSI) between 2013 and 2015. Results: Among 108705 respondents, 7.0% reported a CRD (3.4% asthma,
2.6% COPD, 1.0% Asthma-COPD Overlap Syndrome). Current smoking was more frequent in the group with CRD
compared to those without (30.8% vs. 25.2%, P5.2.001), as was physical inactivity (41.9% vs. 36.4%, P6.4.009) and
overweight/obesity (52.4% vs. 41.4%, P1.4.001). Adults with CRDs also reported appropriate perception of insuf-
ficient physical activity and excessive body weight, adopted protective behaviours and received preventive inter-
ventions more often than those without CRDs. Conclusions: Italian adults with CRDs are more likely to be exposed
to aggravating factors but are also knowledgeable of their condition and amenable to behaviour change. Since
effective interventions for modifying these factors are available, there is an opportunity to reduce the significant
disease burden of CRDs through specifically targeted health promotion interventions.
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Introduction
Chronic respiratory diseases (CRDs) comprise multiple diseases ofthe airways and lungs, such as asthma, chronic obstructive
pulmonary disease (COPD), sleep apnea syndrome and other lung
diseases arising from occupational exposure. While these conditions
differ in their aetiology, anatomical and functional alterations, clinical
course and treatment, they share several common factors, acting both
as aggravating and risk factors, in people with and without CRDs,
respectively. Collectively CRDs are associated with a significant
burden on healthcare systems, as well as on society.1–4 Overall, the
impact of CRDs on population health could be improved through the
reduction of risk/aggravating factors, in particular, tobacco smoking,
second-hand smoke, indoor and outdoor air pollutants, occupational
agents, overweight/obesity and physical inactivity, along with the im-
plementation of preventive measures, such as flu vaccination, and
appropriate treatments. Indeed, effective management plans have
been shown to reduce morbidity and mortality from these diseases.1
The main objective of these analyses is to provide an updated
estimate of CRDs in the adult Italian population (18–69 years)
utilizing data from the Italian behavioural risk factor surveillance
system (BRFSS), PASSI (Progressi delle Aziende Sanitarie per la
Salute in Italia). The specific objectives are (i) to estimate the
prevalence of CRDs, overall and in different population groups, and
(ii) to assess the occurrence of modifiable risk/aggravating factors for
CRDs, protective individual behaviours and preventive interventions
in people with and without CRDs to better target new policies.
Methods
PASSI is an ongoing cross-sectional Italian BRFSS. The sample for
the survey is extracted from the Italian adult population 18–
69 years old, which comprised 41 057 512 individuals on 1
January 2014.
The unit of data collection for PASSI is the local health unit (LHU).
Each of the 20 Italian Regions comprises 1–22 LHUs in charge of
providing universal health care, including prevention and treatment
services for populations ranging from 40 000 to over one million.
The survey population includes residents in the LHU area
(18–69 years) who have a telephone number available (landline or
cell phone) and are capable of being interviewed; a sample of
potential interviewees is randomly drawn from the enrolment list
of residents in each LHU on a monthly basis. People who have
moved away or deceased when a contact is attempted, are not
considered in the eligible population; other criteria of exclusion
are inability to understand Italian, inability to participate in the
interview, hospitalisation or institutionalisation and being out of
the age range (18–69). The sample is stratified by gender and age
(18–34, 35–49 and 50–69 years) proportionally to the size of the
respective strata in the general population. Specially trained LHU
public health practitioners administer telephone interviews
(minimum 25 per month in each LHU) through a standardized
questionnaire, gathering information on a wide variety of health-
related behavioural and preventive topics along with socio-demo-
graphic data. Informed verbal consent is obtained from all the par-
ticipants. The data are anonymized and electronically recorded in a
national database. Interviews collected during a calendar year are
aggregated in an annual dataset. The LHUs’ data are merged and
analyzed to obtain regional and national estimates. The protocol of
PASSI surveillance was approved by the ethics committee of the
National Institute of Public Health.5
Annual datasets for the years 2013, 2014 and 2015 were combined
to ensure sufficient sample size for exploring population subgroups.
During the study period 112 114 people were interviewed in 128 out
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of 139 (92%) Italian LHUs. The survey participants represented 90%
of the Italian population.
In the first weeks of 2013, some LHUs conducted the interviews
through a previous version of the questionnaire, which did not allow
to distinguish among the different categories of CRDs. We excluded
those interviews (3409) and the final analysis was performed on
108 705 records.
The outcome rates were calculated following the guidelines of the
American Association for Public Opinion Research (AAPOR).6 The
response rate (RR) adjusted for ineligible cases (AAPOR RR4) was
83% in the cumulative 2013–2015 sample (84% in 2013, 83% in
2014 and 82% in 2015). Small variations in the RRs of subgroups
were observed in the cumulative 2013–2015 sample: 84% in women,
82% in men; 82%, 82% and 84% in the 18–34, 35–49 and 50–
69 years age groups, respectively. Item non-response for the
questions on CRDs was negligible (0.1%), as well as for the other
variables used in the analysis (never higher than 0.4%). Details about
these methodological issues have been described elsewhere.5 Figure 1
describes the participants in a flow diagram.
Indicator definitions
Information on CRDs is collected by asking whether the participant
has been diagnosed by a physician for (i) asthma and (ii) chronic
bronchitis, emphysema or respiratory failure (COPD). According to
these questions, four different indicators were created: (a) asthma
only, if participants responded ‘yes’ only to question (i); (b) COPD
only, if participants responded ‘yes’ only to question (ii); (c) asthma—
COPD overlap syndrome (ACOS)7 if participants responded ‘yes’
both to question (i) and to question (ii); (d) any CRD, if participants
responded ‘yes’ to question (i) or/and to question (ii).
Information on socio-demographic characteristics, sex, age (18–
34, 35–49 or 50–69 years), completed education (none or primary
school, middle school, high school, university), economic difficulties
(many, some or no difficulties in getting to the end of the month
with the available household income) and geographic area of
residence (North, Centre or South and major islands, according to
the criteria of the Italian National Institute of Statistics) were
collected, too. Sex, age and residence were objectively confirmed
with the LHUs’ lists. Other indicators are described in Appendix.
Statistical analysis
Percentage estimates were weighted, assigning each record a prob-
ability weight equal to the inverse of the sampling fraction in each
LHU stratum. Complex survey design analyses were conducted,
using the Taylor series method for variance estimation.
The characteristics of the population under study were described
through a frequency distribution of the main socio-demographic
variables and behavioural risk/aggravating factors. Prevalence of
any CRD, and of each component condition, was calculated
overall and by socio-demographic characteristics, reporting 95%
confidence intervals. A Poisson regression model was used to
estimate adjusted prevalence ratios for evaluating the association
between CRDs and socio-demographic characteristics.
To allow comparisons with other surveys which used different age
strata, we calculated the estimates for the specific age groups presented
by those studies, reported in table 2. For the same purpose, since many
surveys do not consider ACOS, we reported also the prevalence of
total asthma and total COPD, aggregating ACOS subjects, respectively,
with people with asthma only and COPD only. Frequency of
aggravating factors, protective behaviours and preventive interven-
tions was estimated in those with and without CRDs.
The association between CRDs and modifiable aggravating and
protective factors was estimated using Poisson regression to obtain
prevalence ratios, crude and adjusted for socio-demographic char-
acteristics. Statistical analyses were performed using the statistical
package Stata 13 (StataCorp LP, TX).
Results
The age and sex distributions of the sample (table 1) closely reflect
those of the resident population2 for the years and geographical
areas considered.
The prevalence of CRDs in the Italian adult population was 7.0%
(3.4% asthma only, 2.6% COPD only and 1.0% ACOS). The
prevalence was significantly higher among older people (adj.PR
1.85; P .85.001), those with lower educational level (primary
school or less) (adj.PR 1.38; P .38.001) and those with many
economic difficulties (adj.PR 1.88; P .88.001). Conversely the
prevalence was significantly lower among people living in
Southern Italy (adj.PR 0.89; P .89.002). The pattern of COPD and
ACOS was similar to that of any CRD with the exception that COPD
was more frequent in Southern Italy (adj.PR 1.22; P .22.002).
Asthma, unlike COPD, ACOS and any CRD was less common
among those with lower educational level and was more frequent
in Northern Italy. No significant gender differences were observed
for CRDs considered together and for each component condition
(table 1). Table 2 shows specific PASSI age group estimates of CRDs
for comparison with other studies.
Table 3 compares the prevalence of modifiable factors in the
groups with and without CRDs. The proportion of current
smokers was higher in those with CRDs, as was the percentage of
those who engaged in no-leisure time physical activity and those that
were overweight or obese. The proportion of individuals reporting
that smoking was allowed in their house was higher in the CRDs
group, as was the proportion of those reporting that the smoking
ban was not respected in the workplace. People with CRDs had a
better perception of their insufficient level of physical activity and of
their excess weight. Moreover, they attempted more often to quit
smoking in the 12 months prior to the interview. Among those in
excess weight, people with CRDs followed a diet to lose weight more
frequently than people without CRDs. Adherence to flu vaccination
was three times higher in people with CRDs and this group also
received more frequent counselling from General Practitioners
(GPs) regarding quitting smoking, doing regular physical activity,
if insufficient, and losing weight, if excessive.
Discussion
The large representative sample of the Italian population in the
PASSI surveillance allows for detailed investigation of the
prevalence and distribution of respiratory conditions in the
general population. The observed association of CRDs with
modifiable aggravating and protective factors provides new
evidence that will help to form policies to improve respiratory
health.
Prevalence of CRDs: comparisons with other studies
The prevalence estimates of CRDs reported here for the Italian
population are within the wide range of estimates reported by inter-
national surveys such as the BOLD study for COPD8 and the World
Health Survey (WHS) for asthma.3 Large geographic variations in
the prevalence of CRDs are also apparent within nations; data of the
American BRFSS (2006–2007; adults 18 years) show marked dif-
ferences among communities in the prevalence of asthma (6.5–
18.9%).9 Similarly in a separate 2011 study, the overall prevalence
of COPD in the United States was 6.3% but wide variations among
States were observed (3.1–9.3%).10
As shown in table 2, PASSI (2013–2015) estimates of any CRD are
higher than those reported by the annual health interview survey of
the Italian National Institute of Statistics (ISTAT). Conversely, the
prevalence of CRDs (physician-diagnosed asthma and/or COPD)
reported by the GEIRD study for subjects aged 20–64 years11 was
substantially higher than the corresponding PASSI value (13% vs.
6.5%). ISTAT and GEIRD are health interview surveys based on self-
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reported data as PASSI, adopting the same cumulative indicator for
CRDs (asthma and/or COPD).
The prevalence of COPD diagnosed by spirometry (GOLD case
definition) in a sample of the general population of an area of
Northern Italy was much higher than that of PASSI: 7% vs. 3.9%
for the 45–59 age group.12 It is not surprising that estimates based
on objective measures of airways obstruction (comprising a sizable
proportion of subclinical cases) are higher than those based on
self-reported, doctor-diagnosed cases. Moreover, the different
geographic representativeness of the samples (sub-regional vs.
national) and the different survey periods must be taken into
account when comparing these results. Analyses of administrative
health databases of Lazio Region, through a validated predictive
model, provide estimates of diagnosed cases of COPD that are
quite similar to PASSI’s: about 3% for the 45–54 age class and
6–7% for 55–64-year-old people.13
It is also possible to compare PASSI Italian national estimates of
respiratory conditions with those of a multinational study (WHS):
in 2002–2003, a 6% prevalence of doctor-diagnosed asthma was
reported for the 18–45 years Italian population, slightly higher
than that found by PASSI (4.1%).3 In general, to correctly
interpret observed differences in prevalence among various studies,
one should bear in mind that CRDs are influenced by multiple risk
factors such as health-related behaviours, occupational and environ-
mental exposures, socio-economic condition, access to health care,
etc., which are unevenly distributed in different geographic areas.
Additional research is needed to investigate which specific causes are
responsible for the observed differences in each geographic and
temporal context.10
Sociodemographic factors
Our findings show a higher prevalence of COPD among older and less
educated people; asthma presented an opposite, but less evident trend
for age and educational level, while ACOS had a distribution pattern
similar to that of COPD. Small, non-significant gender differences
were observed in the prevalence of CRDs between women and men.
Our results are comparable with those of other Italian studies,11,14
while in other nations gender differences are more marked.15
Moreover, COPD, with or without asthma, was more frequently
observed in people with economic difficulties. It is widely
acknowledged that the risk of developing COPD is inversely related
to socio economic status (SES), both in high and in low-and-middle
income countries;4,16 low SES is associated with worse health
outcomes,17 even if access to medications is equitable.18 In people
with more economic difficulties we found the prevalence of asthma,
alone, was slightly higher than in those with none or some economic
difficulties, which is consistent with the results of various studies.19–21
Modifiable aggravating and protective factors
Overall, people with CRDs had a significantly higher prevalence of
risk/aggravating factors compared to those without CRDs, while also
Figure 1 Participants flow diagram
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reporting protective health-related perceptions and behaviours more
often than those without CRDs. For example, while smoking was
more prevalent in those with CRDs, the same group reported more
frequent attempts to quit smoking. In addition, people with CRDs
reported environmental tobacco smoke exposure in the home and
workplace more often than those without CRDs; both exposures are
amenable to public health strategies and interventions.
Smokers with CRDs were more likely to have received advice from
a GP to quit; similarly, overweight/obese people with CRDs received
more frequently advice to lose weight. In people with asthma, weight
loss is associated with improvements in symptoms and lung
function, decrease in asthma severity and medication use22 and
presents an additional opportunity to improve outcomes for
people with this condition.
Obese COPD patients experience greater respiratory symptoms,
more severe restriction of daily activities, poorer health-related
quality of life and greater health care use.23 On the other hand,
other studies have shown that overweight/obese patients with
COPD do not have higher mortality rates than normal-weight
subjects. This ‘obesity paradox’ is explained by the fact that in
COPD patients a strong predictor of overall mortality is muscle
wasting which can be found in a proportion of COPD patients
with a normal BMI.24 More precisely, COPD patients in the lower
range of a normal BMI (<23) appear to have a mortality higher than
patients in excess weight.25 This fact must be considered in planning
and implementing interventions aimed at obtaining a weight loss in
these patients.
According to the PASSI survey results, people with CRDs were
also more likely to be physically inactive, but had correct perceptions
of the insufficient Physical Activity (PA) levels, and received advice
from GPs about exercise more frequently than people without
CRDs. Physical inactivity is associated with a low-grade systemic
Table 1 Distribution of socio-demographic characteristics of the Italian adult population; prevalence of any Chronic Respiratory Disease
(CRD), Asthma only, Chronic Obstructive Pulmonary Disease (COPD) only, Asthma-COPD Overlap Syndrome (ACOS), by socio-demographic
characteristics; association between CRDs and socio-demographic characteristics
Characteristics Italian adult
population
Any CRD Asthma only COPD only ACOS
Proportion of any CRD (%) – 100 48 38 14
Mean age (years) 44.3 49.2 43.2 55.2 53.7
(95%CI) (44.2–44.3) (48.9–49.4) (42.9–43.5) (54.7–55.6) (53.1–54.4)
Distribution Prevalence Prevalence Prevalence Prevalence
% % Adj. PR a % Adj. PR a % Adj. PR a % Adj. PR a
(95% CI) (P value) (95% CI) (P value) (95% CI) (P value) (95% CI) (P value)
Overall – 7.0 3.4 2.6 1.0
(6.8–7.3) (3.3–3.6) (2.5–2.8) (0.9–1.0)
Age group 18–34 27.6 4.8 1 3.7 1 0.8 1 0.3 1
(4.5–5.2) (3.5–4.1) (0.6–0.9) (0.3–0.4)
35–49 34.5 5.7 1.13 3.4 0.90 1.6 2.0 0.7 1.88
(5.4–6.0) (0.006) (3.2–3.7) (0.062) (1.4–1.8) (0.001) (0.6–0.8) (0.001)
50–69 37.9 9.9 1.85 3.2 0.85 5.0 5.7 1.7 3.99
(9.5–10.3) (0.001) (2.9–3.4) (0.005) (4.7–5.4) (0.001) (1.5–1.8) (0.001)
Total 100.0
Gender Male 49.4 6.8 1 3.3 1 2.6 1 0.9 1
(6.5–7.1) (3.1–3.5) (2.4–2.8) (0.8–1.0)
Female 50.6 7.3 1.03 3.5 1.05 2.8 0.99 1.0 1.05
(7.0–7.6) (0.347) (3.3–3.7) (0.290) (2.5–3.0) (0.091) (0.9–1.1) (0.588)
Total 100.0
Educational
attainment
University 16.2 5.6 1 3.8 1 1.4 1 0.4 1
(5.2–6.1) (3.5–4.2) (1.2–1.6) (0.3–0.5)
High school 46.7 6.0 0.97 3.4 0.86 1.9 1.16 0.7 1.55
(5.7–6.3) (0.541) (3.2–3.6) (0.010) (1.7–2.1) (0.133) (0.6–0.8) (0.007)
Middle school 29.5 8.0 1.08 3.4 0.83 3.4 1.43 1.2 2.01
(7.6–8.5) (0.117) (3.1–3.6) (0.006) (3.2–3.7) (0.001) (1.1–1.4) (0.001)
Primary school or less 7.6 12.9 1.38 3.1 0.80 7.1 1.90 2.7 3.00
(11.9–14.1) (0.001) (2.6–3.7) (0.033) (6.3–8.1) (0.001) (2.3–3.2) (0.001)
Total 100.0
Perceived economic
difficultiesb
None 41.6 5.4 1 3.2 1 1.6 1 0.6 1
(5.2–5.7) (3.0–3.4) (1.5–1.8) (0.5–0.6)
Some 41.8 7.2 1.31 3.3 1.14 2.9 1.52 1.0 1.51
(6.9–7.6) (0.001) (3.1–3.6) (0.005) (2.7–3.2) (0.001) (0.8–1.1) (0.001)
Many 16.6 10.7 1.88 4.1 1.49 4.6 2.17 2.0 2.89
(10.1–11.4) (0.001) (3.7–4.5) (0.001) (4.1–5.1) (0.001) (1.7–2.3) (0.001)
Total 100.0
Geographic area of
residencec
North 39.5 7.0 1 3.9 1 2.2 1 0.9 1
(6.7–7.2) (3.7–4.1) (2.1–2.4) (0.8–1.0)
Centre 22.1 7.0 0.97 3.4 0.87 2.5 1.06 1.1 1.15
(6.7–7.4) (0.288) (3.2–3.7) (0.002) (2.3–2.7) (0.304) (0.9–1.2) (0.131)
South/major islands 38.4 7.1 0.89 2.9 0.69 3.2 1.22 1.0 0.89
(6.7–7.6) (0.002) (2.6–3.2) (0.001) (2.9–3.6) (0.002) (0.9–1.1) (0.234)
Total 100.0
Source: PASSI 2013–2015 (n = 108705)
a: Adj. PR (adjusted prevalence ratio): adjusted for age, gender, educational attainment, perceived economic difficulties and geographic
area of residence.
b: Reporting no difficulty, some difficulty or much difficulty in getting to the end of the month with the available income.
c: Defined according to the census criteria of the Italian National Institute of Statistics; Southern Italy comprises the two Italian major
islands (Sardinia and Sicily).
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inflammation, that might influence the induction and clinical
expression of asthma and COPD.26,27 In people with asthma,
moderate to high PA improves lung function.28 Patients with
COPD can significantly improve their exercise tolerance and
quality of life, and reduce symptoms of dyspnea and fatigue with
only a minor increment in their leisure-time PA.24,29 Moreover,
moderate PA is associated with a lower risk of hospital admissions
for COPD, and of all-cause and respiratory mortality.30 Even vac-
cination against influenza, which can reduce the risk of serious
illness, hospitalization and death in patients with COPD,24 while
being higher in the CRD group (26%) was far lower than the
targets specified by the Italian Ministry of Health (minimum and
Table 3 Occurrence of modifiable aggravating and protective factors for CRDs, in people with and without CRDs: prevalence and
prevalence ratios
People with CRDs People without CRDs Crude PRa P value Adj. PRb P value
% (95% CI) % (95% CI)
Risk/aggravating
factors
Current smoking 30.8 (29.3–32.3) 25.2 (24.9–25.6) 1.22 <0.001 1.23 <0.001
Smoking ban not respected in the workplace 9.9 (8.7–11.3) 7.5 (7.2–7.8) 1.32 <0.001 1.31 <0.001
Smoking allowed in the house 25.8 (24.3–27.3) 19.6 (19.3–20.0) 1.31 <0.001 1.25 <0.001
Overweight/obesity 52.4 (50.8–54.1) 41.4 (41.0–41.8) 1.26 <0.001 1.11 <0.001
Health-related
perception
No leisure-time physical activity 41.9 (40.3–43.6) 36.4 (36.1–36.8) 1.15 <0.001 1.05 0.009
Correct perception of insufficient physical
activity level (among inactive people)
82.1 (79.8–84.2) 76.0 (75.3–76.5) 1.08 <0.001 1.08 <0.001
Correct perception of excessive body weight
(among overweight and obese)
64.8 (62.3–67.1) 56.6 (56.0–57.2) 1.14 <0.001 1.11 <0.001
Protective
behaviours
Adherence to the most recent flu vaccination
campaign
26.0 (24.0–28.2) 8.4 (8.1–8.7) 3.11 <0.001 2.52 <0.001
Attempt to quit smoking in the last year (among
cigarette smokers)
40.5 (37.7–43.5) 31.4 (30.7–32.2) 1.29 <0.001 1.32 <0.001
Diet to lose weight (among overweight and
obese)
27.0 (25.1–29.1) 23.0 (22.4–23.5) 1.18 <0.001 1.14 0.001
Preventive
interventions
Advice from a GP to quit smoking (among
cigarette smokers)
69.7 (66.8–72.4) 49.6 (48.7–50.4) 1.41 <0.001 1.32 <0.001
Advice from a GP to do regular physical activity
(among inactive people)
33.3 (30.8–36.1) 25.6 (25.0–26.3) 1.30 <0.001 1.25 <0.001
Advice from a GP to lose weight(among
overweight and obese)
59.1 (56.7–61.6) 48.6 (47.9–49.2) 1.22 <0.001 1.17 <0.001
Source: PASSI 2013–2015 (n=108705).
a: Crude PR (crude prevalence ratio).
b: Adj. PR (adjusted prevalence ratio): adjusted for age, gender, educational attainment, perceived economic difficulties and geographic
area of residence.
Table 2 Prevalence of people with Chronic Respiratory Diseases (CRDs) in the Italian general population, by specific age groups
Study Study design Respiratory
condition
Case
definition
Years Geographic
area
Age
group
Prevalence
(%)
Passi
estimate (%)
ISTAT—Indagine
multiscopo
‘Aspetti della vita
quotidiana’36
Cross-sectional health
interview survey (HIS)
Any CRDa Self-reported
condition
2014 Whole Italian
population
18–19 2.7 4.3
20–24 2.8 4.6
25–34 2.9 4.7
35–44 3.3 5.3
45–54 4.1 6.4
55–59 4.9 7.9
60–64 7.3 12.3
de Marco 2013
(GEIRD)11
Cross-sectional HIS Any CRD Self-reported
physician
diagnosis
2007–2010 Four Italian sub-
regional areas
20–64 13 6.5
Guerriero 201512 Cross-sectional health
examination survey
(HES)
Total COPDb Spirometry (GOLD
case definition)
2012 One sub-regional
area of
Northern Italy
45–59 7d 3.9
Belleudi 201213 Record linkage of admin-
istrative health
databases
Total COPD Validated
predictive
model
2008 One Italian Region
(Lazio)
45–54 M 3d 3.4
45–54 F 3d 3.1
55–64 M 7d 6.6
55–64 F 6d 6.5
To 20123 Cross-sectional HIS Total asthmac Self-reported
doctor-
diagnosed
condition
2002–2003 Whole Italian
population
18–45 6.0 4.1
Source: Comparisons of PASSI results (2013–2015) with other studies.
a: Asthma and/or COPD.
b: COPD, with or without asthma.
c: Asthma, with or without COPD.
d: Approximate rounded values derived from diagrams (figure 2 in Guerriero12 and figure 2 in Belleudi13).
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optimal coverage: 75% and 95%, respectively). Together the
evidence from this survey suggests that the Italian population is
amenable to interventions that may reduce the risk of CRDs as
well as mitigate the burden of these diseases.
It is worth noting that the risk/aggravating factors identified for
CRDs are closely related to other Non-communicable Chronic
Diseases (NCDs). This fact is relevant for the management of
patients with CRDs since the majority of them have other co-
existing NCDs and multimorbidity is associated with poorer
outcomes and higher health service use.31 Thus, public health inter-
ventions aimed at tackling these factors can have an additional
positive effect on the population overall health.1
Limitations of the study
The chronic respiratory conditions investigated by PASSI do not
represent the whole range of the CRDs. However, asthma and
chronic obstructive pulmonary diseases are the most widespread.1
In general, self-reported data are subject to various biases such as
recall (past events may be inaccurately recalled because of several
factors, such as time elapsed to interview or differential retrieving of
memories), telescoping (recalling events as having occurred closer to
the time of interview than is true) and social desirability (socially
undesirable behaviours are prone to under-reporting). For instance,
self-reported BMI tend to underestimate real values.32
In particular, identifying individuals with CRDs is susceptible to
misclassification bias. The prevalence of respiratory diseases in the
general population is ideally assessed by objective measurements, but
may be underestimated by self-reported data.33 However, the extent
of inaccurate classification depends on the case definition, which
may differ widely based on the objectives of the study.12,34 The
prevalence of self-reported doctor-diagnosed disease is nonetheless
important and can be used to allocate resources for clinical care. For
this purpose, questions regarding ‘physician-reported’ asthma offer
the highest specificity and are also the most reliable.35 Moreover, the
subjective questions in the PASSI survey cannot be validated with
objective measures.
Since the population under study is between the ages of 18 and 69,
a limitation of this analysis is its lack of assessment of the CRDs
burden for children, young people and the elderly. Identifying the
behaviours associated with CRDs in the adult population (18–
69 years) will guide preventive policies, which in turn may have an
impact on CRDs burden on the entire population.
No data were available on environmental air pollution and occu-
pational hazards, which represent two important risk/aggravating
factors for CRDs. Ecological information about environmental
variables could be derived by linking the micro-area of residence
to maps of air pollution, which we do intend to explore in the
future.
Conclusions
To our knowledge, this is the first nation-wide population-based
study that contributes to the knowledge on the epidemiology of
CRDs in Italy. In this study, we assess the prevalence of ACOS, a
condition not extensively investigated so far. The large representative
sample allowed investigation of the distribution of respiratory
conditions in the adult population as well as the associations
between CRDs and multiple modifiable aggravating and protective
factors, including those not explored by other studies, such as
second hand smoke, individual behaviours and perceptions,
preventive interventions, doctors’ advice. People with CRDs are
more aware of their condition and amenable to modify their
behaviours, which presents an opportunity to develop appropriate
strategies for health promotion and prevention in order to address
the growing burden of CRDs. Lastly, in the choice of preventive
interventions best suited to the various subpopulations, it should
be kept in mind that CRDs in Italy, as in many other countries,
disproportionally affect disadvantaged population groups.
Key points
 This is the first nation-wide population-based study
contributing to the epidemiology of CRDs and of their
risk and protective factors in Italy.
 Italian adults with CRDs are more likely to be current
smokers, physically inactive and overweight, but at the
same time are more aware of their condition and
amenable to modify behaviours.
 CRDs in Italy disproportionally affect disadvantaged
population groups.
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